FDA Adverse Event Injury Summary report: N

WINGSPAN STENT

MDR report key: 1912876 · Received December 2, 2010

Report

Report Number
2939204-2010-01135
Event Type
Injury
Date Received
December 2, 2010
Report Date
November 30, 2010
Manufacturer
BOSTON SCIENTIFIC - FREMONT
Product Code
NJE
PMA / PMN Number
H050001
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LITERATURE: COSTALAT ET AL, NEUROSURGERY 2010: 67(6); 1505-15 - (B)(4).

Additional Manufacturer Narrative · 1

CONCLUSION: ANTICIPATED PROCEDURAL COMPLICATION. THE DEVICE REMAINS IMPLANTED SO WAS NOT AVAILABLE FOR EVALUATION. FROM THE INFORMATION PROVIDED THERE IS NO INDICATION THAT THERE WAS ANY DEVICE MALFUNCTION, NONCONFORMANCE OR MISUSE THAT CONTRIBUTED TO THE REPORTED EVENT. RESTENOSIS IS A KNOWN AND ANTICIPATED COMPLICATION TO THESE TYPES OF PROCEDURES AND IS NOTED AS SUCH IN THE DIRECTIONS FOR USE. THEREFORE IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION.

Description of Event or Problem · 1

IT WAS REPORTED IN AN ARTICLE IN NEUROSURGERY THAT A PATIENT HAD KNOWN MILD RESIDUAL C3 STENOSIS AND AN IN-STENT RESTENOSIS WAS SUSPECTED AT SIX MONTH FOLLOW UP BUT THE PATIENT REFUSED ANGIOGRAPHIC FOLLOW UP AND WAS AYMPTOMATIC. NO TREATMENT WAS GIVEN AND THERE WAS NO CHANGE IN MRS SCORE OF NEUROLOGICAL STATUS.

Description of Event or Problem · 1

IT WAS REPORTED IN AN ARTICLE IN NEUROSURGERY THAT A PATIENT HAD KNOWN MILD RESIDUAL C3 STENOSIS AND AN IN-STENT RESTENOSIS WAS SUSPECTED AT SIX MONTH FOLLOW UP BUT THE PATIENT REFUSED ANGIOGRAPHIC FOLLOW UP AND WAS AYMPTOMATIC. NO TREATMENT WAS GIVEN AND THERE WAS NO CHANGE IN MRS SCORE OF NEUROLOGICAL STATUS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 WINGSPAN STENT STENT, INTRACRANIAL NEUROVASCULAR NJE BOSTON SCIENTIFIC - FREMONT UNK484

Patients

Seq Age Sex Outcome Treatment
1 Other GATEWAY PTA BALLOON CATHETER (BOSTON SCIENTIFIC)